HealthQuill PrEP
ViiV Healthcare, majority owned by GSK, has signed a pact with the UN-backed Medicines Patent Pool (MPP) to enable generic access to its HIV treatment in 133 countries.
Drugs Health Pharma

ViiV to grant generic access to its HIV medicine to benefit 133 nations

HQ Team July 15, 2025: ViiV Healthcare, majority owned by GSK, has signed a pact with the UN-backed Medicines Patent Pool (MPP) to.

Read More
Gilead Sciences, Inc.’s twice-yearly injectable drug for the prevention of HIV in adults and adolescents got approval from the US regulator.
Uncategorized

Gilead’s Yeztugo drug for HIV prevention in adults gets FDA nod

HQ Team June 19, 2025: Gilead Sciences, Inc.’s twice-yearly injectable drug for the prevention of HIV in adults and adolescents got approval from.

Read More
The National Instituted of Health, US, has started a mid-stage clinical trial to examine the safety and acceptability of a rectal microbicide douche containing the antiretroviral drug tenofovir to prevent HIV infection spread among men.
Drugs Health Pharma

Mid-stage trial of a rectal microbicide for HIV prevention in the US begins 

HQ Team November 3, 2024: The National Instituted of Health, US, has started a mid-stage clinical trial to examine the safety and acceptability.

Read More
Aurobindo Pharma, an Indian maker of generic pharmaceuticals and active pharmaceutical ingredients, announced it signed a voluntary sub-licensing with a UN body for developing and marketing a drug to prevent HIV.
Drugs Health Medical Pharma

Aurobindo Pharma signs licensing pact with UN body to fight HIV

Aurobindo Pharma, an Indian maker of generic pharmaceuticals and active pharmaceutical ingredients, announced it signed a voluntary sub-licensing with a UN body for.

Read More